Targeting retroviral vectors to CD34-Expressing cells: Binding to CD34 does not catalyze virus-cell fusion

Human Gene Therapy

Volumn 10, Issue 4, 1999, Pages 545-557

  Benedict, Chris A ^a   Tun, Richard Y M ^a   Rubinstein, Daniel B ^b   Guillaume, Thierry ^c   Cannon, Paula M ^a   Anderson, W French ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD34 ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; ASSAY; CELL FUSION; CELL STRAIN 3T3; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; MURINE LEUKEMIA VIRUS; NONHUMAN; RETROVIRUS; VIRUS PARTICLE;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; BASE SEQUENCE; DNA PRIMERS; GENE PRODUCTS, ENV; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA VIRUS, MURINE; MICE; TRANSDUCTION, GENETIC;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0033106289     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018625     Document Type: Article

References (44)

1. AGER, S., NILSON, B.H.K., MORLING, F., PENG, K.W., COSSET, F.L., and RUSSELL, S.J. (1996). Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity. Hum. Gene Ther. 7, 2157-2164.
2. ANDERSON, W.F. (1999). Human gene therapy. Nature (London) 392, 25-30.
3. BATTINI, J.L., HEARD, J.M., and DANOS, O. (1992). Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66, 1468-1475.
4. BENEDICT, C.A., MACKRELL, A.J., and ANDERSON, W.F. (1996). Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay. J. Immunol. Methods 201, 223-231.
5. BENEDICT, C.A., ZHAO, Y., KASAHARA, N., CANNON, P.M., and ANDERSON, W.F. (1999). Development of retroviral vectors that target hematopoietic stem cells. Hematopoietic cell therapy. In: Hematopoietic Stem Cell Therapy. A.D. Ho and R.E. Champlin, eds. (Cambridge University Press, New York) (in press).
6. CIVIN, C.I., STRAUSS, L.C., BROVALL, C., FACKLER, M.J., SCHWARTZ, J.F., and SHAPER, J.H. (1984). A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 133, 157-165.
7. COSSET, F.L., and RUSSELL, S.J. (1996). Targeting retrovirus entry. Gene. Ther. 3, 946-956.
8. COSSET, F.L., MORLING, F.J., TAKEUCHI, Y., WEISS, R.A., COLLINS, M.K.L., and RUSSELL, S. (1995). Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69, 6314-6322.
9. EGLITIS, M.A., SCHNEIDERMAN, R.D., RICE, P.M., and EIDEN, M.V. (1995). Evaluation of retroviral vectors based on the gibbon ape leukemia virus. Gene Ther. 2, 486-492.
10. ETIENNE-JULAN, M., ROUX, P., CARILLO, S., JEANTEUR, P., and PIECHACZYK, M. (1992). The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and composition of the artificial cell-virus linker. J. Gen. Virol. 73, 3251-3255.
11. FASS, D., DAVEY, R.A., HAMSON, C.A., KIM, P.S., CUNNINGHAM, J.M., and BERGER, J.M. (1997). Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277, 1662-1666.
12. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MULLER, G., HILLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracycline in mammalian cells. Science 268, 1766-1769.
13. GOUD, B., LEGRAIN, P., and BUTTIN, G. (1988). Antibody-mediated binding of a murine ecotropic Moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state. Virology 163, 251-254.
14. HALL, F.L., GORDON, E.M., WU, L., ZHU, N.-L., SKOTZKO, M.J., STARNES, V.A., and ANDERSON, W.F. (1997). Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMuLV gp70 envelope protein. Hum. Gene Ther. 8, 2183-2192.
15. HAN, J.Y., CANNON, P.M., LAI, K.M., ZHAO, Y., EIDEN, M.V., and ANDERSON, W.F. (1997). Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus. J. Virol. 71, 8103-8108.
16. HEARD, J.M., and DANOS, O. (1991). An ammo-terminal fragment of the Friend murine leukemia virus envelope glycoprotein. J. Virol. 65, 4026-4032.
17. HO, S.N., HUNT, H.D., HORTON, R.M., PULLEN, J.K., and PLEASE, L.R. (1989). Site-directed mutagenesis by overlap extension using polymerase chain reaction. Gene 77, 51-59.
18. JANUSZESKI, M.M., CANNON, P.M., CHEN, D., ROSENBERG, Y., and ANDERSON, W.F. (1997). Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 71, 3613-3619.
19. KADAN, M.J., STURMS, S., ANDERSON, W.F., and EGLITIS, M.A. (1992). Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol. 66, 2281-2287.
20. KASAHARA, N., DOZY, A.M., and KAN, Y.W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373-1376.
21. KRAUSE, D.S., FACKLER, M.J., CIVIN, C.I., and MAY, W.S. (1996). CD34: Structure, biology, and clinical utility. Blood 87, 1-13.
22. MACKRELL, A.J., SOONG, N.W., CURTIS, C.M., and ANDERSON, W.F. (1996). Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J. Virol. 70, 1768-1774.
23. MANN, R., MULLIGAN, R.C., and BALTIMORE, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-159.
24. MARIN, M., NOEL, D., VALSESIA-WITTMAN, S., BROCKLY, F., ETIENNE-JULAN, M., RUSSELL, S., COSSET, F.L., and PIECHACZYK, M. (1996). Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain anti-body fragment-envelope fusion proteins. J. Virol. 70, 2957-2962.
25. MORGAN, R.A., NUSSBAUM, O., MUENCHAU, D.D., SHU, L., COUTURE, L., and ANDERSON, W.F. (1993). Analysis of the functional and host range-determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins. J. Virol. 67, 4712-4721.
26. NEDA, H., WU, C., and WU, G. (1991). Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. J. Biol. Chem. 266, 141-143.
27. OSAWA, M., HANADA, K.I., HAMADA, H., and NAKAUCHI, H. (1996). Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242-245.
28. OTT, D., and REIN, A. (1991). Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70 SU. J. Virol. 66, 4632-4638.
29. OXLEY, S., and SACKSTEIN, R. (1994). Detection of an L-selectin ligand on a hematopoietic progenitor cell line. Blood 84, 3299-3306.
30. PARKER, B.A., and STARK, G.R. (1979). Regulation of simian virus 40 transcription: Sensitive analysis of the RNA species present early in infections by virus or viral DNA. J. Virol. 31, 360-369.
31. RAGHEB, J.A., and ANDERSON, W.F. (1994). Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: A functional analysis of the role of TM domains in viral entry. J. Virol. 68, 3207-3219.
32. REIN, A., MIRRO, J., HAYNES, J.G., ERNST, S.M., and NAGASHIMA, K. (1994). Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68, 1773-1781.
33. ROUX, P., JEANTEUR, P., and PIECHACZYK, M. (1989). A versatile and potentially general approach to the targeting of specific cell types by retroviruses: Application to the infection of human cells by means of major histocompatibility complex class I and class II anti-gens by mouse ecotropic murine leukemia virus derived viruses. Proc. Natl. Acad. Sci. U.S.A. 86, 9079-9083.
34. RUBINSTEIN, D.B., LEBLANC, P., WRIGHT, D.G., GUILLAUME, T., STROTCHEVOI, A., and BOOSALIS, M. (1999). Anti-CD34+ Fabs generated against hematopoietic stem cells in HIV-derived combinatorial immunoglobulin library suggest antigen-selected autoantibodies. Mol. Immunol. (in press).
35. RUSSELL, S.J., HAWKINS, R.E., and WINTER, G. (1993). Retroviral vectors displaying factional antibody fragments. Nucleic Acids Res. 21, 1081-1085.
36. SCHNIERLE, B.S., and GRONER, B. (1996). Retroviral targeted delivery. Gene Ther. 3, 1069-1073.
37. SCHNIERLE, B.S., MORITZ, D., JESCHKE, M., and GRONER, B. (1996). Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther. 3, 334-342.
38. SOMIA, N.V., ZOPPE, M., and VERMA, I.M. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl. Acad. Sci. U.S.A. 92, 7570-7574.
39. SONEOKA, Y., CANNON, P.M., RAMSDALE, E.E., GRIFFITHS, C., ROMANO, G., KINGSMAN, S.M., and KINGSMAN, A.J. (1995). A transient three plasmid expression system for the production of high titre retroviral vectors. Nucleic Acids Res. 23, 628-633.
40. TERSTAPPEN, L.M., HUANG, S., SAFFORD, M., LANSDORP, P.M., and LOKEN, M.R. (1991). Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38-progenitor cells. Blood 77, 1218-1227.
41. WHITE, J.M. (1992). Membrane fusion. Science 258, 917-924.
42. ZHAO, Y., LEE, S., and ANDERSON, W.F. (1997). Functional interactions between monomers of the retroviral envelope protein complex. J. Virol. 71, 6967-6972.
43. ZHAO, Y., ZHU, L., BENEDICT, C., CHEN, D., ANDERSON, W.F., and CANNON, P.M. (1998). Functional domains in the retroviral transmembrane protein. J. Virol. 72, 5392-5398.
44. ZHU, N.-L., CANNON, P.M., CHEN, D., and ANDERSON, W.F. (1998). Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E. J. Virol. 72, 1632-1639.